<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Lebœuf M</submitter><funding>European Research Council</funding><funding>Association Nationale de la Recherche et de la Technologie</funding><pagination>e56525</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10398658</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>24(8)</volume><pubmed_abstract>Several homeoprotein transcription factors transfer between cells and regulate gene expression, protein translation, and chromatin organization in recipient cells. ENGRAILED-1 is one such homeoprotein expressed in spinal V1 interneurons that synapse on α-motoneurons. Neutralizing extracellular ENGRAILED-1 by expressing a secreted single-chain antibody blocks its capture by spinal motoneurons resulting in α-motoneuron loss and limb weakness. A similar but stronger phenotype is observed in the Engrailed-1 heterozygote mouse, confirming that ENGRAILED-1 exerts a paracrine neurotrophic activity on spinal cord α-motoneurons. Intrathecal injection of ENGRAILED-1 leads to its specific internalization by spinal motoneurons and has long-lasting protective effects against neurodegeneration and weakness. Midbrain dopaminergic neurons express Engrailed-1 and, similarly to spinal cord α-motoneurons, degenerate in the heterozygote. We identify genes expressed in spinal cord motoneurons whose expression changes in mouse Engrailed-1 heterozygote midbrain neurons. Among these, p62/SQSTM1 shows increased expression during aging in spinal cord motoneurons in the Engrailed-1 heterozygote and upon extracellular ENGRAILED-1 neutralization. We conclude that ENGRAILED-1 might regulate motoneuron aging and has non-cell-autonomous neurotrophic activity.</pubmed_abstract><journal>EMBO reports</journal><pubmed_title>ENGRAILED-1 transcription factor has a paracrine neurotrophic activity on adult spinal α-motoneurons.</pubmed_title><pmcid>PMC10398658</pmcid><funding_grant_id>2017/0488</funding_grant_id><funding_grant_id>339379</funding_grant_id><pubmed_authors>Lebœuf M</pubmed_authors><pubmed_authors>Peze-Hedsieck E</pubmed_authors><pubmed_authors>Vargas-Abonce SE</pubmed_authors><pubmed_authors>Prochiantz A</pubmed_authors><pubmed_authors>Jimenez-Alonso L</pubmed_authors><pubmed_authors>Moya KL</pubmed_authors><pubmed_authors>Dupont E</pubmed_authors></additional><is_claimable>false</is_claimable><name>ENGRAILED-1 transcription factor has a paracrine neurotrophic activity on adult spinal α-motoneurons.</name><description>Several homeoprotein transcription factors transfer between cells and regulate gene expression, protein translation, and chromatin organization in recipient cells. ENGRAILED-1 is one such homeoprotein expressed in spinal V1 interneurons that synapse on α-motoneurons. Neutralizing extracellular ENGRAILED-1 by expressing a secreted single-chain antibody blocks its capture by spinal motoneurons resulting in α-motoneuron loss and limb weakness. A similar but stronger phenotype is observed in the Engrailed-1 heterozygote mouse, confirming that ENGRAILED-1 exerts a paracrine neurotrophic activity on spinal cord α-motoneurons. Intrathecal injection of ENGRAILED-1 leads to its specific internalization by spinal motoneurons and has long-lasting protective effects against neurodegeneration and weakness. Midbrain dopaminergic neurons express Engrailed-1 and, similarly to spinal cord α-motoneurons, degenerate in the heterozygote. We identify genes expressed in spinal cord motoneurons whose expression changes in mouse Engrailed-1 heterozygote midbrain neurons. Among these, p62/SQSTM1 shows increased expression during aging in spinal cord motoneurons in the Engrailed-1 heterozygote and upon extracellular ENGRAILED-1 neutralization. We conclude that ENGRAILED-1 might regulate motoneuron aging and has non-cell-autonomous neurotrophic activity.</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Aug</publication><modification>2025-07-02T03:04:19.342Z</modification><creation>2025-04-06T17:46:03.623Z</creation></dates><accession>S-EPMC10398658</accession><cross_references><pubmed>37534581</pubmed><doi>10.15252/embr.202256525</doi></cross_references></HashMap>